BIO-Europe Spring is taking place in Barcelona from 11th to 13th March. It is the springtime counterpart to BIO-Europe, Europe’s largest partnering conference serving the global biotechnology industry. The event, held in Barcelona for the second time,continues the tradition of providing life science companies with high caliber partnering opportunities. The Innovation Management Office of the Clínic Foundation for Biomedical Research, a professional team that manages its own projects as well as innovation from Hospital Clínic of Barcelona, IDIBAPS and CRESIB, is there with a highly competitive portfolio of innovative ideas to be licensed.
Archive for the ‘Hospital Clínic’ Category
On 16 February, Dr. Montse Palacio, from the Maternal Fetal Medicine service of the Hospital Clinic, received the Excellence Award of Research , one of the prestigious awards offered by the Society for Maternal-Fetal Medicine (SMFM). This award and the study, entitled Vaginal progesterone as maintenance treatment after an episode of preterm labor (PROMISE Study): a randomized, double blinded, placebo-controlled trial were presented as part of the thirteenth annual meeting of the SMFM, held in San Francisco from 11 to 16, February 2013. Read the rest of this entry »
One of the main events of the seventeenth annual meeting of the Catalan Society of Neurology (SCN), held on 7 and 8 March in Sitges, is the ceremony of its honorary awards. Dr Josep Dalmau, ICREA investigator leading the Autoimmunity against synaptic antigens IDIBAPS group, has been awarded the 2012 professional career award. On the other hand, Dr Eduard Tolosa, from the IDIBAPS research team on Neurodegenerative diseases: Clinical and Experimental Research, has received the Honorary Member Award of the 40th anniversary of the modern SCN. These distinguished researchers have been awarded together with the former Catalan President, Molt Hble. Sr. Pasqual Maragall, who receives the honorific award “Galceran i Granés. 100 years of Catalan Society of Neurology”.
With the slogan “Health begins before birth”, inatal has been created to provide accurate information, useful and transparent about this stage of life. With inatal they seek to promote the active participation among pregnants through forums in which both they and their families and associations, can answer their questions and concerns with rigor and more reliably.
The anti-NMDA autoimmune encephalitis is a disease described in 2005 by a team led by Dr. Josep Dalmau at the University of Pennsylvania (USA). In this disorder the patient’s immune system attacks the NMDA receptors in the brain, which are important for neuronal plasticity. It triggers a wide range of symptoms such as psychosis, behavioral disturbances, memory deficit or loss of consciousness that may be confused with severe psychiatric disorders. The disease affects mainly women, especially young ones. Nowadays Dr. Josep Dalmau heads, thanks to a senior ICREA contract, the Autoimmunity against synaptic antigens IDIBAPS group. In collaboration with colleagues at the University of Pennsylvania, where he keeps collaborating, and other international partners, his team published in Lancet Neurology the keys to successfully treat over 80% of these patients. The first author is Dr. Maarten Titulaer, a Dutch researcher who works at Dr. Dalmau’s IDIBAPS team.
The plenary session of the Institute of Catalan Studies (Institut d’Estudis Catalans – IEC) agreed on February 25 to include four new members. The columnist, enigmist, storyteller and translator Màrius Serra and the teacher Vicent Pascual, who played a key role in the introduction of Catalan in the Valencian school in the last thirty years, joined the Philological Section. Doctors Jordi Salas-Salvadó, from the Hospital Universitari Sant Joan de Reus, and Ramon Gomis, Director of IDIBAPS, joined the Biological Sciences Section.